Top Medical News

Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell Therapy

August 12th 2022

Sherry Adkins, MSN, ANP-C, discusses some key considerations in ensuring quality patient care after they have completed CAR T-cell therapy at a specialized center.

HER2-Directed Therapy, Trastuzumab Deruxtecan, Approved for Metastatic NSCLC

August 12th 2022

The FDA has approved trastuzumab deruxtecan for patients with HER2-mutated non–small cell lung cancer after the DESTINY-Lung02 results demonstrated a 57% overall response rate with the agent. The drug comes with warning for interstitial lung disease, neutropenia, and left ventricular dysfunction.

Capmatinib Snags Full FDA Approval for MET Exon 14 Skipping NSCLC

August 11th 2022

The FDA has granted capmatinib regular approval for patients with metastatic non–small cell lung cancer (NSCLC) whose tumors have a mutation leading to MET exon 14 skipping. The drug comes with warning for pneumonitis, hepatotoxicity, and pancreatic toxicity.

Structured Onboarding Processes Boost Employee Retention

August 11th 2022

In an unprecedented age of health care burnout, hospital administrators may need to think outside of the box to find ways to engage and support employees.

Approaches to Urothelial Care Call for Nuanced AE Management

August 11th 2022

Avelumab, erdafitinib, and enfortumab vedotin-ejfv are 3 critical drugs in the treatment of urothelial cancer with distinct safety profiles, according to a presentation at the 6th Annual School of Nursing Oncology™ Meeting.

Most Recent